loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 202611 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 MIRABEGRON (2)

filter

01 APGDI (2)

filter

01 TABLET, EXTENDED RELEASE;ORAL (2)

filter

01 25MG (1)

02 50MG (1)

filter

01 USA (2)

Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
TABLET, EXTENDED RELEA...
50MG
MYRBETRIQ
USA
202611
2012-06-28
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
TABLET, EXTENDED RELEA...
25MG
MYRBETRIQ
USA
202611
2012-06-28
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 202611

Looking for CTD TGA MCC DOSSIER APPLICATION 202611 2

19

APGDI, based in U.S.A, is a pharmaceutical company.

One of their notable products is MIRABEGRON, with a corresponding application number 202611 and regulatory information .

proudly manufactured in the

approval since 2012-06-28

APGDI's MYRBETRIQ TABLET, EXTENDED RELEASE;ORAL, medication with 50MG of MIRABEGRON.

18

APGDI, based in U.S.A, is a pharmaceutical company.

One of their notable products is MIRABEGRON, with a corresponding application number 202611 and regulatory information .

proudly manufactured in the

approval since 2012-06-28

APGDI's MYRBETRIQ TABLET, EXTENDED RELEASE;ORAL, medication with 25MG of MIRABEGRON.

Post Enquiry
POST ENQUIRY